Promethazine hydrochloride at a concentration of 0.033 mg/ml has pronounced effects on leukocyte metabolism and function. The drug inhibits the phagocytosisinduced increases in 02 consumption and hexose monophosphate shunt activity. Associated with these effects is an inhibition of the iodination of zymosan particles and an inhibition of bacterial killing by the cell. At least two mechanisms appear to be involved. Many of the effects can be explained by an inhibition of phagocytosis, but promethazine also inhibits the decarboxylation of amino acids and iodide fixation in a cell-free system, indicating a specific effect on metabolism. These results may partially account for the action of the drug in ameliorating the effects of erythroblastosis. She ascribed the effectiveness of the drug to its diuretic properties. Gusdon et al. (4) then demonstrated that administrationi of l)romethazine to experimental animals resulted in inhibition of both the primary and secondary immune response and delayed hypersensitivity. However, depression of circulating anti-Rh antibody titers has been noted in only some of the patients treated with the drug (J. P. Gusdon, unpublished data). The present investigation was undertaken to study the effects of the drug on a specific cell associated with the inflammatory response in an effort to more clearly define the mechanism of action of the drug.
tologie, Toulouse, France, 1967) first suggested an amelioration of the effects of erythroblastosis in babies whose mothers had been treated with promethazine-hydrochloride during pregnancy.
She ascribed the effectiveness of the drug to its diuretic properties. Gusdon et al. (4) then demonstrated that administrationi of l)romethazine to experimental animals resulted in inhibition of both the primary and secondary immune response and delayed hypersensitivity. However, depression of circulating anti-Rh antibody titers has been noted in only some of the patients treated with the drug (J. P. Gusdon, unpublished data). The present investigation was undertaken to study the effects of the drug on a specific cell associated with the inflammatory response in an effort to more clearly define the mechanism of action of the drug.
MATERIALS AND METHODS
All isotopes were obtained from the New England Nuclear Corp., Boston, Mass. D-Glucose-1-'4C and D-glucose-6-14C (specific activities 54.2 mCi/ mmol and 36.5 mCi/mmol, respectively) were dissolved in deionized water to give an activity of 2.0 JMCi/ml. D-Glucose-1-14C-6-phosphate was obtained as the disodium salt and diluted with deionized water to anl activity of 2.0 ;sCi/ml; unlabeled glucose-6-phosphate was added to give a specific activity of 0.60 mCi/mmol. L-Alanine-1 -14C (specific activity 13 .2 mCi/mmol) was obtained in 0.5 ml of 0.1 N HCI. The HCI was evaporated under a stream of nitrogen, and the isotope was dissolved in deionized water to give an activity of 5.0 uCi/ml. Carrier-free Na'15I was obtained at a concentration of 5 mCi in 0.10 ml. A stock solution of 50 ICi/0.10 ml was prepared in 10 ml of sterile deionized water. Since the half-life of 1251-is 54 days, the activity was adjusted weekly. All biochemicals were obtained from the Sigma Chemical Co., St. Louis, Mo.; all other chemicals were of reagent grade quality. Hanks balanced salt solution (HBSS) and latex particles (0.8-,um diameter) were obtained from Difco Laboratories, Detroit, Mich. The latex particles were washed three times in cold deionized water by repeatedsuspension and centrifugation (6,040 X g for 15 min). The washed pellet was suspended in isotonic saline, such that a 1 to 100 dilution would have an absorbance of 0.42 at 540 nm. The final concentration of latex was approximately 3 X 109 particles/ml. Plasma gel, used in sedimenting the red blood cells, was obtained from the HTI Corp., Buffalo, N.Y. Zymosan particles were obtained from Nutritional Biochemicals Corp., Cleveland, Ohio. They were suspended in HBSS to a concentration of approximately 6 X 109 particles per ml. Serum was derived from a pool of human AB type serum kept frozen in small samples at -70 C. Promethazine-hydrochloride (Phenergan) was supplied as the pure powder by the Wyeth Laboratories, Philadelphia, Pa. Purified human myeloperoxidase was the generous gift of Jutlius Schultz.
Isolation of leukocytes. Leukocytes were isolated from the blood of apparently healthy volunteer subjects by a method previously described (2) . For experiments requiring intact cells, the cells were counted by conventional means and 403 404DECHATELET ET AL. the concentration was adjusted to 5 X 106 cells/ml by the addition of HBSS. Differential counts were done in a counting chamber by classifying cells as phagocytes (mature and band form neutrophils, eosinophils, and monocytes) and lymphocytes.
Lymphocytes accounted for less than 10%/ of the isolated cell suspension. Cell viability was determined by staining with 1% trypan blue dye.
For experiments in which broken cell preparations were used, the cells were suspended in phosphate-buffered saline and disrupted by sonic treatment for 1 min using a Branson sonifier with a power output of 20 W. Examination of the sonically treated material by phase-contrast microscopy indicated total cell disruption.
Measurement of glucose utilization. Glucose utilization via the hexose monophosphate shunt (HMS) was estimated by a modification of a previously described method (5), employing glucose differentially labeled in the C-1 or C-6 position. Each flask contained 0.20 ml of serum, 0.10 ml of KCN (0.01 M), and 0.10 ml of either glucose-1-14C or glucose-6-4C. Promethazine-hydrochloride was added to experimental flasks dissolved in HBSS; an equal volume of HBSS was added to control flasks. Phagocytosis was initiated by the addition of 1.0 ml of a suspension of heatkilled Escherichia coli (1.0 X 1011 bacteria/ml). This concentration was demonstrated experimentally to give maximal stimulation of the HMS. The volume of all flasks was brought to a final total of 3.0 ml (after the addition of cells) with HBSS. Reaction was initiated by the addition of 1.0 ml of cell suspension (containing 5 X 106 cells) and allowed to proceed for 1 h at 37 C. 14CO2 was collected in 0.5 ml of hyamine hydroxide and counted in a liquid scintillation spectrometer as previously described (5) . The oxidation of glucose-6-phosphate-1-14C in a cell-free system was measured as previously described (12) .
Leukocyte oxygen consumption. Oxygen consumption was measured by use of a Clark oxygen electrode with an automatic recorder according to a modification of a previously reported method (11) . Each chamber contained in a final volume of 3.0 ml:0.50 ml of serum, 0.10 ml of KCN (0.01 M), 1.0 ml of cell suspension (5 X 106 cells per ml), and HBSS to give total volume of 3.0 ml). Promethazine-hydrochloride dissolved in 0.10 ml of HBSS was added where indicated.
Phagocytosis was initiated in appropriate flasks by the addition of 1.0 ml of heat-killed E. coli. The oxygen consumption was calculated as micromoles of oxygen consumed per hour per 5 X 106 cells.
Bactericidal assay. The clearance of bacteria by the polymorphonuclear leukocytes was determined by the plate dilution technique of Maal0e (8) as previously described. The drug was added to appropriate flasks in a minimal volume (0.10 ml) of HBSS.
Phagocytosis assay. Phagocytosis of microorganisms was quantitated by measuring leukocyte uptake of radiolabeled E. coli as previously described (10) . The ingestion of latex particles was estimated by determining the phagocytic index. The phagocytes (1 X 107) were incubated in 10% serum in HBSS with latex particles at a ratio of 100 particles per phagocyte for 15 min. Five hundred cells were then examined by phase microscopy, and the number of particles in each cell was estimated. The index was calculated on the basis of 0 to 5 for each individual phagocyte. Thus, the phagocytic score could range from 0 to 2,500.
lodination reaction. The ability of the intact cell to iodinate ingested particles was measured by a modification of the method of Pincus and Klebanoff (9) as previously described (10). lodination of zymosan particles in a cell-free system was determined by the procedure of Klebanoff (6) . Each incubation tube contained in a total volume of 1.0 ml: 200 pmol of sodium acetate buffer, pH 5.0; 0.2 pmol of H202; 0.2 pmol of Nal"'I containing 0.50 uCi of radioactivity; 2 X 108 zymosan particles; 10 pg of purified human myeloperoxidase (200-o-dianisidine units); and varying amounts of promethazine-hydrochloride. Controls in which either the zymosan or the myeloperoxidase were omitted were run. The reaction was stopped after 1 h at 37 C by the addition of 1.0 ml of cold 5% trichloroacetic acid. The resulting precipitates were washed and counted as described by Klebanoff (6) . Aldehyde reaction. The decarboxylation of L-alanine-1-14C was taken as a measure of aldehyde formation according to the procedure of Strauss et al. (12) .
Enzyme assays. Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase were measured by observing the initial rate of formation of nicotinamide adenine dinucleotide phosphate (reduced) at 340 nm in a Beckman DU spectrophotometer with a Gilford recorder (7). Myeloperoxidase activity was determinded by the o-dianisidine dye procedure (13) . RESULTS The effect of promethazine on the HMS activity of phagocytizing leukocytes is demonstrated in Fig. 1 . It is apparent that a concentration of promethazine as low as 0.033 mg/ml (0.1 mM) completely abolishes the respiratory burst. This effect is not due to an inhibition of the HMS enzymes glucose-6-phosphate dehydrogenase or 6-phosphogluconate dehydrogenase as demonstrated by the data in Table 1 . In this experiment, the oxidation of glucose-6-phosphate-1-14C by sonic extracts of polymorphonuclear leukocytes in the presence of exogenous nicotinamide adenine dinucleotide phosphate was determined as previously described (11) . The fact that promethazine exerts no effect on this system indicates that it does not act as an inhibitor of the HMS enzymes, as has been demonstrated for colchicine (3) tion of promethazine of 0.17 mg/ml had no effect on the activity of leukocyte glucose-6-phosphate dehydrogenase or 6-phosphogluconate dehydrogenase (data not shown). Table 2 illustrates the effect of promethazinehydrochloride on the oxygen consumption of human polymorphonuclear leukocytes. A concentration of promethaziine of 0.033 mg/ml inhibits the oxygen consumption of resting cells by more than 50% and lowers the oxygen consumption of phagocytizing cells to below the normal resting level. The Figure 2 illustrates the effect of the drug on the }3ecause the ability of the cell to destroy bacteria has been correlated with iodination of the ingested particles, we studied the effects of promethazine on the fixation of 125I to zymosan particles. The data (Table 3 ) demonstrate a 70% inhibition of iodination at a concentration of 0.033 mg of promethazine per ml. Iodination is completely abolished at the higher concentration of the drug.
Since all the parameters studied to this point utilized whole cells, they were dependent upon the ability of particles to enter the cell as well as the subsequent intracellular events. Hence, it was considered important to determine the effects of promethazine on particle ingestion per se. The data in Table 4 and Fig. 3 indicate that promethazine can exert a pronounced effect on the ingestion of either latex particles or radiolabeled E. coli.
Another reaction which has been implicated in bactericidal activity is the myeloperoxidasecatalyzed formation of aldehydes from amino acids. Figure 4 shows that this reaction, too, is markedly suppressed by the drug. This is of particular interest because this reaction is performed in a cell-free system and is therefore independent of any effects on phagocytosis.
Since we had previously demonstrated that promethazine could inhibit iodination of zymosan by intact leukocytes (Table 3) , it now became of interest to determine whether the drug would affect iodination in a cell-free system. The results in Table 5 clearly indicate that promethazine will inhibit iodination independently of an effect on particle uptake. The iodination reaction, however, is not nearly as sensitive to the drug as is the formation of aldehydes from amino acids.
Both iodination and aldehyde formation are dependent upon the enzyme myeloperoxidase. Accordingly, it was hypothesized that prometha- zine was an inhibitor of myeloperoxidase. To test this hypothesis, the enzyme was assayed by the o-dianisidine procedure in the presence and absence of the drug. The data in Table 6 indicate that a concentration of promethazine as high as 0.167 mg/ml has absolutely no effect on the activity of myeloperoxidase, indicating that the ent investigation of the effects of the drug on the polymorphonuclear leukocytes. The administration of promethazine-hydrochloride to the mother results in a transfer of the drug to the fetus (1). The amelioration of erythroblastosis by promethazine might be due to the inhibition of the metabolism of the fetal reticuloendothelial cells responsible for red cell lysis. Studies of the effects of promethazine on other cells of the reticuloendothelial system are in progress.
